{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:18:04Z","timestamp":1782404284094,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","award":["305056\/2019-0"],"award-info":[{"award-number":["305056\/2019-0"]}]},{"name":"Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","award":["301358\/2017-6"],"award-info":[{"award-number":["301358\/2017-6"]}]},{"name":"Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","award":["401346\/2020-0"],"award-info":[{"award-number":["401346\/2020-0"]}]},{"name":"Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","award":["303197\/2017-0"],"award-info":[{"award-number":["303197\/2017-0"]}]},{"DOI":"10.13039\/501100005942","name":"Funda\u00e7\u00e3o Butantan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005942","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2020\/05293-0"],"award-info":[{"award-number":["2020\/05293-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The new outbreak of coronavirus disease 2019 (COVID-19) has infected and caused the death of millions of people worldwide. Intensive efforts are underway around the world to establish effective treatments. Immunoglobulin from immunized animals or plasma from convalescent patients might constitute a specific treatment to guarantee the neutralization of the virus in the early stages of infection, especially in patients with risk factors and a high probability of progressing to severe disease. Worldwide, a few clinical trials using anti-SARS-CoV-2 immunoglobulins from horses immunized with the entire spike protein or fragments of it in the treatment of patients with COVID-19 are underway. Here, we describe the development of an anti-SARS-CoV-2 equine F(ab\u2032)<jats:sub>2<\/jats:sub> immunoglobulin using a newly developed SARS-CoV-2 viral antigen that was purified and inactivated by radiation. Cell-based and preclinical assays showed that the F(ab\u2032)<jats:sub>2<\/jats:sub> immunoglobulin successfully neutralizes the virus, is safe in animal models, and reduces the severity of the disease in a hamster model of SARS-CoV-2 infection and disease.<\/jats:p>","DOI":"10.1038\/s41598-022-07793-1","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T11:06:06Z","timestamp":1646910366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Anti-SARS-CoV-2 equine F (Ab\u2032)2 immunoglobulin as a possible therapy for COVID-19"],"prefix":"10.1038","volume":"12","author":[{"given":"Viviane Fongaro","family":"Botosso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraia Attie Calil","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato Mancini","family":"Astray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Marcia","family":"de S\u00e1 Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Beatriz","family":"Mathor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia dos Santos","family":"de Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edison Luiz","family":"Durigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimas","family":"Covas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Bruna Leal","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"das Neves Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durvanei Augusto","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silas Fernandes","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neuza Maria Frazatti","family":"Gallina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Pidde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Cristina","family":"Squaiella-Baptist\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilza Trevisan","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isadora Maria","family":"Villas-Boas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayanne Carla","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Vivian Vatti","family":"Auada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Campos","family":"Banari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Francisco","family":"de Souza Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Bianconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Lilian","family":"de Agostini Utescher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Cristina Andr\u00e9","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Oscar Ceolin","family":"Mariano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Ferreira","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Rondon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josana","family":"Kapronezai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Galv\u00e3o","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio Barbugiani","family":"Goldfeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila","family":"Comone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis Edgar Castilho","family":"Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiana Tain\u00e1 Silva","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan Hui","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise V.","family":"Tambourgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Marisa","family":"Chudzinski-Tavassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"7793_CR1","unstructured":"JHUM. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). (2020). https:\/\/coronavirus.jhu.edu\/map.html. (accessed 20 Jan 2007)."},{"key":"7793_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25685","author":"G Li","year":"2020","unstructured":"Li, G. et al. Coronavirus infections and immune responses. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.25685 (2020).","journal-title":"J. Med. Virol."},{"key":"7793_CR3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00072-20","author":"D Focosi","year":"2020","unstructured":"Focosi, D., Anderson, A. O., Tang, J. W. & Tuccori, M. Convalescent plasma therapy for covid-19: State of the art. Clin. Microbiol. Rev. https:\/\/doi.org\/10.1128\/CMR.00072-20 (2020).","journal-title":"Clin. Microbiol. Rev."},{"key":"7793_CR4","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/jmv.25961","volume":"92","author":"K Rajendran","year":"2020","unstructured":"Rajendran, K. et al. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. J. Med. Virol. 92, 1475\u20131483 (2020).","journal-title":"J. Med. Virol."},{"key":"7793_CR5","doi-asserted-by":"publisher","first-page":"100843","DOI":"10.1016\/j.eclinm.2021.100843","volume":"34","author":"G Lopardo","year":"2021","unstructured":"Lopardo, G. et al. RBD-specific polyclonal F(ab\u00b4)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2\/3 clinical trial. EClinicalMedicine 34, 100843 (2021).","journal-title":"EClinicalMedicine"},{"key":"7793_CR6","doi-asserted-by":"publisher","first-page":"9825","DOI":"10.1038\/s41598-021-89242-z","volume":"11","author":"G Le\u00f3n","year":"2021","unstructured":"Le\u00f3n, G. et al. Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19. Sci. Rep. 11, 9825 (2021).","journal-title":"Sci. Rep."},{"key":"7793_CR7","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3389\/fmed.2021.743325","volume":"8","author":"A Alape-Gir\u00f3n","year":"2021","unstructured":"Alape-Gir\u00f3n, A. et al. Heterologous hyperimmune polyclonal antibodies against SARS-CoV-2: A broad coverage, affordable, and scalable potential immunotherapy for COVID-19. Front. Med. 8, 1517 (2021).","journal-title":"Front. Med."},{"key":"7793_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2090","author":"L Du","year":"2009","unstructured":"Du, L. et al. The spike protein of SARS-CoV\u2014A target for vaccine and therapeutic development. Nat. Rev. Microbiol. https:\/\/doi.org\/10.1038\/nrmicro2090 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"7793_CR9","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","author":"VM Corman","year":"2020","unstructured":"Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.3.2000045 (2020).","journal-title":"Eurosurveillance"},{"key":"7793_CR10","doi-asserted-by":"publisher","unstructured":"Araujo, D. B. et al. SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network. Mem. Inst. Oswaldo Cruz. 115 e200342 https:\/\/doi.org\/10.1590\/0074-02760200342 (2020).","DOI":"10.1590\/0074-02760200342"},{"key":"7793_CR11","doi-asserted-by":"crossref","unstructured":"Hierholzer, J. C., Killington, R. A. Virus isolation and quantification. In Virology Methods Manual (ed. Kangro, H. B. M.) 24\u201332 (Academic Press Inc, 1996).","DOI":"10.1016\/B978-012465330-6\/50003-8"},{"key":"7793_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469 (2020).","journal-title":"Nature"},{"key":"7793_CR13","unstructured":"Brasil. Guia para a condu\u00e7\u00e3o de estudos n\u00e3o cl\u00ednicos de toxicologia e seguran\u00e7a farmacol\u00f3gica necess\u00e1rios ao desenvolvimento de medicamentos. Ag\u00eancia de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA). (2013)."},{"key":"7793_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.pathol.2020.09.007","volume":"52","author":"SS Tan","year":"2020","unstructured":"Tan, S. S. et al. Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays. Pathology 52, 770\u2013777 (2020).","journal-title":"Pathology"},{"key":"7793_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/JVI.79.1.503-511.2005","volume":"79","author":"A Roberts","year":"2005","unstructured":"Roberts, A. et al. Severe acute respiratory syndrome coronavirus infection of golden syrian hamsters. J. Virol. 79, 503\u2013511 (2005).","journal-title":"J. Virol."},{"key":"7793_CR16","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1165\/rcmb.2020-0280LE","volume":"63","author":"AD Gruber","year":"2020","unstructured":"Gruber, A. D. et al. Standardization of reporting criteria for lung pathology in SARS-CoV-2-infected hamsters: What matters?. Am. J. Respir. Cell Mol. Biol. 63, 856\u2013859 (2020).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"7793_CR17","doi-asserted-by":"publisher","first-page":"2632010X2095182","DOI":"10.1177\/2632010X20951823","volume":"13","author":"B Geramizadeh","year":"2020","unstructured":"Geramizadeh, B. & Marzban, M. Histopathologic findings of coronavirus in lung: A mini-review. Clin. Pathol. 13, 2632010X2095182 (2020).","journal-title":"Clin. Pathol."},{"key":"7793_CR18","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.cell.2020.09.049","volume":"183","author":"J Kreye","year":"2020","unstructured":"Kreye, J. et al. A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 Hamster model. Cell 183, 1058\u20131069 (2020).","journal-title":"Cell"},{"key":"7793_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1348-0421.1992.tb02045.x","volume":"36","author":"N Cimolai","year":"1992","unstructured":"Cimolai, N., Taylor, G. P., Mah, D. & Morrison, B. J. Definition and application of a histopathological scoring scheme for an animal model of acute mycoplasma pneumoniae pulmonary infection. Microbiol. Immunol. 36, 465\u2013478 (1992).","journal-title":"Microbiol. Immunol."},{"key":"7793_CR20","first-page":"291","volume":"23","author":"AC Ruifrok","year":"2001","unstructured":"Ruifrok, A. C. & Johnston, D. A. Quantification of histochemical staining by color deconvolution. Anal. Quant. Cytol. Histol. 23, 291\u2013299 (2001).","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"7793_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/jimaging5030035","volume":"5","author":"R Mukundan","year":"2019","unstructured":"Mukundan, R. Analysis of image feature characteristics for automated scoring of HER2 in histology slides. J. Imaging 5, 35 (2019).","journal-title":"J. Imaging"},{"key":"7793_CR22","first-page":"3","volume":"42","author":"YA Malik","year":"2020","unstructured":"Malik, Y. A. Properties of coronavirus and SARS-CoV-2. Malays. J. Pathol. 42, 3\u201311 (2020).","journal-title":"Malays. J. Pathol."},{"key":"7793_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","volume":"182","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell 182, 713\u2013721 (2020).","journal-title":"Cell"},{"key":"7793_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3390\/pathogens10050626","volume":"10","author":"AK Sundaram","year":"2021","unstructured":"Sundaram, A. K. et al. Immunogenicity of adjuvanted psoralen-inactivated Sars-Cov-2 vaccines and Sars-Cov-2 spike protein DNA vaccines in balb\/c mice. Pathogens 10, 626 (2021).","journal-title":"Pathogens"},{"key":"7793_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.virol.2021.01.003","volume":"558","author":"JS Terry","year":"2021","unstructured":"Terry, J. S. et al. Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody. Virology 558, 28\u201337 (2021).","journal-title":"Virology"},{"key":"7793_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198182","author":"S Shahrudin","year":"2018","unstructured":"Shahrudin, S. et al. Gamma-irradiated rotavirus: A possible whole virus inactivated vaccine. PLoS\u00a0One https:\/\/doi.org\/10.1371\/journal.pone.0198182 (2018).","journal-title":"PLoS\u00a0One"},{"key":"7793_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1535676020934242","volume":"25","author":"A Leung","year":"2020","unstructured":"Leung, A. et al. In vitro inactivation of SARS-CoV-2 using gamma radiation. Appl. Biosaf. 25, 157\u2013160 (2020).","journal-title":"Appl. Biosaf."},{"key":"7793_CR28","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1038\/s41598-021-83930-6","volume":"11","author":"G Sir Karakus","year":"2021","unstructured":"Sir Karakus, G. et al. Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates. Sci. Rep. 11, 5804 (2021).","journal-title":"Sci. Rep."},{"key":"7793_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.03.007","author":"S Jiang","year":"2020","unstructured":"Jiang, S., Hillyer, C. & Du, L. Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol. https:\/\/doi.org\/10.1016\/j.it.2020.03.007 (2020).","journal-title":"Trends Immunol."},{"key":"7793_CR30","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMc2100362","volume":"384","author":"SS Abdool Karim","year":"2021","unstructured":"Abdool Karim, S. S. & de Oliveira, T. New SARS-CoV-2 variants\u2014Clinical, public health, and vaccine implications. N. Engl. J. Med. 384, 1866\u20131868 (2021).","journal-title":"N. Engl. J. Med."},{"key":"7793_CR31","doi-asserted-by":"publisher","unstructured":"Palacios, R. et al. Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: The PROFISCOV Study. SSRN Electron. J. 66, https:\/\/doi.org\/10.2139\/ssrn.3822780 (2021).","DOI":"10.2139\/ssrn.3822780"},{"key":"7793_CR32","doi-asserted-by":"publisher","unstructured":"Veras, F. P. et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J. Exp. Med. 217(12), e20201129 https:\/\/doi.org\/10.1084\/jem.20201129 (2020).","DOI":"10.1084\/jem.20201129"},{"key":"7793_CR33","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.3389\/fimmu.2020.614256","volume":"11","author":"AC Fagre","year":"2020","unstructured":"Fagre, A. C. et al. A potent SARS-CoV-2 neutralizing human monoclonal antibody that reduces viral burden and disease severity in Syrian hamsters. Front. Immunol. 11, 3385 (2020).","journal-title":"Front. Immunol."},{"key":"7793_CR34","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.abc7520","volume":"369","author":"TF Rogers","year":"2020","unstructured":"Rogers, T. F. et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science (80-). 369, 956\u2013963 (2020).","journal-title":"Science (80-)."},{"key":"7793_CR35","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.cell.2020.06.011","volume":"182","author":"AO Hassan","year":"2020","unstructured":"Hassan, A. O. et al. A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies. Cell 182, 744-753.e4 (2020).","journal-title":"Cell"},{"key":"7793_CR36","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","volume":"173","author":"KB Renegar","year":"2004","unstructured":"Renegar, K. B., Small, P. A., Boykins, L. G. & Wright, P. F. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J. Immunol. 173, 1978\u20131986 (2004).","journal-title":"J. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07793-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07793-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07793-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T23:51:51Z","timestamp":1669333911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07793-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7793"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-07793-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3890"}}